世界の悪性黒色腫薬市場：市場規模・現状・予測

• 英文タイトル：Global Malignant Melanoma Drugs Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7503
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、悪性黒色腫薬のグローバル市場について調査・分析したレポートで、種類別（免疫療法、ターゲット療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・悪性黒色腫薬の世界市場規模
・主要企業別市場シェア
・悪性黒色腫薬の世界市場規模：種類別（免疫療法、ターゲット療法、その他）
・悪性黒色腫薬の世界市場規模：用途別（病院、診療所、その他）
・悪性黒色腫薬のアメリカ市場規模（種類別、用途別）
・悪性黒色腫薬のヨーロッパ市場規模（種類別、用途別）
・悪性黒色腫薬の中国市場規模（種類別、用途別）
・悪性黒色腫薬の日本市場規模（種類別、用途別）
・悪性黒色腫薬の東南アジア市場規模（種類別、用途別）
・悪性黒色腫薬のインド市場規模（種類別、用途別）
・悪性黒色腫薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・悪性黒色腫薬の世界市場予測（2019年-2025年）
・悪性黒色腫薬の地域別市場予測（2019年-2025年）
...

In 2018, the global Malignant Melanoma Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Malignant Melanoma Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Malignant Melanoma Drugs development in United States, Europe and China.

The key players covered in this study
Bristol-Myers Squibb
Enzon Pharmaceuticals
Exelixis
GlaxoSmithKline
Merck
Pfizer
Janssen Biotech
Hoffmann-La Roche Ltd
Navidea Biopharmaceuticals
Novartis
Ono Pharmaceutical
Amgen

Market segment by Type, the product can be split into
Immunotherapy
Targeted Therapy
Other

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Malignant Melanoma Drugs status, future forecast, growth opportunity, key market and key players.
To present the Malignant Melanoma Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Malignant Melanoma Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Malignant Melanoma Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Immunotherapy
1.4.3 Targeted Therapy
1.4.4 Other
1.5 Market by Application
1.5.1 Global Malignant Melanoma Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Malignant Melanoma Drugs Market Size
2.2 Malignant Melanoma Drugs Growth Trends by Regions
2.2.1 Malignant Melanoma Drugs Market Size by Regions (2014-2025)
2.2.2 Malignant Melanoma Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Malignant Melanoma Drugs Market Size by Manufacturers
3.1.1 Global Malignant Melanoma Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Malignant Melanoma Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Malignant Melanoma Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Malignant Melanoma Drugs Key Players Head office and Area Served
3.3 Key Players Malignant Melanoma Drugs Product/Solution/Service
3.4 Date of Enter into Malignant Melanoma Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Malignant Melanoma Drugs Market Size by Type (2014-2019)
4.2 Global Malignant Melanoma Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Malignant Melanoma Drugs Market Size (2014-2019)
5.2 Malignant Melanoma Drugs Key Players in United States
5.3 United States Malignant Melanoma Drugs Market Size by Type
5.4 United States Malignant Melanoma Drugs Market Size by Application

6 Europe
6.1 Europe Malignant Melanoma Drugs Market Size (2014-2019)
6.2 Malignant Melanoma Drugs Key Players in Europe
6.3 Europe Malignant Melanoma Drugs Market Size by Type
6.4 Europe Malignant Melanoma Drugs Market Size by Application

7 China
7.1 China Malignant Melanoma Drugs Market Size (2014-2019)
7.2 Malignant Melanoma Drugs Key Players in China
7.3 China Malignant Melanoma Drugs Market Size by Type
7.4 China Malignant Melanoma Drugs Market Size by Application

8 Japan
8.1 Japan Malignant Melanoma Drugs Market Size (2014-2019)
8.2 Malignant Melanoma Drugs Key Players in Japan
8.3 Japan Malignant Melanoma Drugs Market Size by Type
8.4 Japan Malignant Melanoma Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Malignant Melanoma Drugs Market Size (2014-2019)
9.2 Malignant Melanoma Drugs Key Players in Southeast Asia
9.3 Southeast Asia Malignant Melanoma Drugs Market Size by Type
9.4 Southeast Asia Malignant Melanoma Drugs Market Size by Application

10 India
10.1 India Malignant Melanoma Drugs Market Size (2014-2019)
10.2 Malignant Melanoma Drugs Key Players in India
10.3 India Malignant Melanoma Drugs Market Size by Type
10.4 India Malignant Melanoma Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Malignant Melanoma Drugs Market Size (2014-2019)
11.2 Malignant Melanoma Drugs Key Players in Central & South America
11.3 Central & South America Malignant Melanoma Drugs Market Size by Type
11.4 Central & South America Malignant Melanoma Drugs Market Size by Application

12 International Players Profiles
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Malignant Melanoma Drugs Introduction
12.1.4 Bristol-Myers Squibb Revenue in Malignant Melanoma Drugs Business (2014-2019)
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Enzon Pharmaceuticals
12.2.1 Enzon Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Malignant Melanoma Drugs Introduction
12.2.4 Enzon Pharmaceuticals Revenue in Malignant Melanoma Drugs Business (2014-2019)
12.2.5 Enzon Pharmaceuticals Recent Development
12.3 Exelixis
12.3.1 Exelixis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Malignant Melanoma Drugs Introduction
12.3.4 Exelixis Revenue in Malignant Melanoma Drugs Business (2014-2019)
12.3.5 Exelixis Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Details
12.4.2 Company Description and Business Overview
12.4.3 Malignant Melanoma Drugs Introduction
12.4.4 GlaxoSmithKline Revenue in Malignant Melanoma Drugs Business (2014-2019)
12.4.5 GlaxoSmithKline Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Malignant Melanoma Drugs Introduction
12.5.4 Merck Revenue in Malignant Melanoma Drugs Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Malignant Melanoma Drugs Introduction
12.6.4 Pfizer Revenue in Malignant Melanoma Drugs Business (2014-2019)
12.6.5 Pfizer Recent Development
12.7 Janssen Biotech
12.7.1 Janssen Biotech Company Details
12.7.2 Company Description and Business Overview
12.7.3 Malignant Melanoma Drugs Introduction
12.7.4 Janssen Biotech Revenue in Malignant Melanoma Drugs Business (2014-2019)
12.7.5 Janssen Biotech Recent Development
12.8 Hoffmann-La Roche Ltd
12.8.1 Hoffmann-La Roche Ltd Company Details
12.8.2 Company Description and Business Overview
12.8.3 Malignant Melanoma Drugs Introduction
12.8.4 Hoffmann-La Roche Ltd Revenue in Malignant Melanoma Drugs Business (2014-2019)
12.8.5 Hoffmann-La Roche Ltd Recent Development
12.9 Navidea Biopharmaceuticals
12.9.1 Navidea Biopharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Malignant Melanoma Drugs Introduction
12.9.4 Navidea Biopharmaceuticals Revenue in Malignant Melanoma Drugs Business (2014-2019)
12.9.5 Navidea Biopharmaceuticals Recent Development
12.10 Novartis
12.10.1 Novartis Company Details
12.10.2 Company Description and Business Overview
12.10.3 Malignant Melanoma Drugs Introduction
12.10.4 Novartis Revenue in Malignant Melanoma Drugs Business (2014-2019)
12.10.5 Novartis Recent Development
12.11 Ono Pharmaceutical
12.12 Amgen

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Malignant Melanoma Drugs Key Market Segments
Table Key Players Malignant Melanoma Drugs Covered
Table Global Malignant Melanoma Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Malignant Melanoma Drugs Market Size Market Share by Type 2014-2025
Figure Immunotherapy Figures
Table Key Players of Immunotherapy
Figure Targeted Therapy Figures
Table Key Players of Targeted Therapy
Figure Other Figures
Table Key Players of Other
Table Global Malignant Melanoma Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Malignant Melanoma Drugs Report Years Considered
Table Global Malignant Melanoma Drugs Market Size 2014-2025 (Million US$)
Figure Global Malignant Melanoma Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Malignant Melanoma Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Malignant Melanoma Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Malignant Melanoma Drugs Market Share by Regions 2014-2019
Figure Global Malignant Melanoma Drugs Market Share by Regions 2014-2019
Figure Global Malignant Melanoma Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Malignant Melanoma Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Malignant Melanoma Drugs Market Share by Manufacturers (2014-2019)
Figure Global Malignant Melanoma Drugs Market Share by Manufacturers in 2018
Table Global Malignant Melanoma Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Malignant Melanoma Drugs Product/Solution/Service
Table Date of Enter into Malignant Melanoma Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Malignant Melanoma Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Malignant Melanoma Drugs Market Size Share by Type (2014-2019)
Figure Global Malignant Melanoma Drugs Market Size Market Share by Type (2014-2019)
Table Global Malignant Melanoma Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Malignant Melanoma Drugs Market Size Share by Application (2014-2019)
Figure Global Malignant Melanoma Drugs Market Size Market Share by Application (2014-2019)
Figure Global Malignant Melanoma Drugs Revenue Market Share by Application in 2018
Figure United States Malignant Melanoma Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Malignant Melanoma Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Malignant Melanoma Drugs Market Share (2018-2019)
Table United States Malignant Melanoma Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Malignant Melanoma Drugs Market Share by Type (2014-2019)
Table United States Malignant Melanoma Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Malignant Melanoma Drugs Market Share by Application (2014-2019)
Figure Europe Malignant Melanoma Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Malignant Melanoma Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Malignant Melanoma Drugs Market Share (2018-2019)
Table Europe Malignant Melanoma Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Malignant Melanoma Drugs Market Share by Type (2014-2019)
Table Europe Malignant Melanoma Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Malignant Melanoma Drugs Market Share by Application (2014-2019)
Figure China Malignant Melanoma Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Malignant Melanoma Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Malignant Melanoma Drugs Market Share (2018-2019)
Table China Malignant Melanoma Drugs Market Size by Type (2014-20189) (Million US$)
Table China Malignant Melanoma Drugs Market Share by Type (2014-2019)
Table China Malignant Melanoma Drugs Market Size by Application (2014-2019) (Million US$)
Table China Malignant Melanoma Drugs Market Share by Application (2014-2019)
Figure Japan Malignant Melanoma Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Malignant Melanoma Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Malignant Melanoma Drugs Market Share (2018-2019)
Table Japan Malignant Melanoma Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Malignant Melanoma Drugs Market Share by Type (2014-2019)
Table Japan Malignant Melanoma Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Malignant Melanoma Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Malignant Melanoma Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Malignant Melanoma Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Malignant Melanoma Drugs Market Share (2018-2019)
Table Southeast Asia Malignant Melanoma Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Malignant Melanoma Drugs Market Share by Type (2014-2019)
Table Southeast Asia Malignant Melanoma Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Malignant Melanoma Drugs Market Share by Application (2014-2019)
Figure India Malignant Melanoma Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Malignant Melanoma Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Malignant Melanoma Drugs Market Share (2018-2019)
Table India Malignant Melanoma Drugs Market Size by Type (2014-2019) (Million US$)
Table India Malignant Melanoma Drugs Market Share by Type (2014-2019)
Table India Malignant Melanoma Drugs Market Size by Application (2014-2019) (Million US$)
Table India Malignant Melanoma Drugs Market Share by Application (2014-2019)
Figure Central & South America Malignant Melanoma Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Malignant Melanoma Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Malignant Melanoma Drugs Market Share (2018-2019)
Table Central & South America Malignant Melanoma Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Malignant Melanoma Drugs Market Share by Type (2014-2019)
Table Central & South America Malignant Melanoma Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Malignant Melanoma Drugs Market Share by Application (2014-2019)
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Malignant Melanoma Drugs Business (2014-2019) (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Malignant Melanoma Drugs Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Enzon Pharmaceuticals Company Details
Table Enzon Pharmaceuticals Revenue in Malignant Melanoma Drugs Business (2014-2019)(Million US$)
Figure Enzon Pharmaceuticals Revenue Growth Rate in Malignant Melanoma Drugs Business (2014-2019)
Table Enzon Pharmaceuticals Recent Development
Table Exelixis Company Details
Table Exelixis Revenue in Malignant Melanoma Drugs Business (2014-2019)(Million US$)
Figure Exelixis Revenue Growth Rate in Malignant Melanoma Drugs Business (2014-2019)
Table Exelixis Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Malignant Melanoma Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Malignant Melanoma Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in Malignant Melanoma Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Malignant Melanoma Drugs Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Malignant Melanoma Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Malignant Melanoma Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Janssen Biotech Company Details
Table Janssen Biotech Revenue in Malignant Melanoma Drugs Business (2014-2019)(Million US$)
Figure Janssen Biotech Revenue Growth Rate in Malignant Melanoma Drugs Business (2014-2019)
Table Janssen Biotech Recent Development
Table Hoffmann-La Roche Ltd Company Details
Table Hoffmann-La Roche Ltd Revenue in Malignant Melanoma Drugs Business (2014-2019)(Million US$)
Figure Hoffmann-La Roche Ltd Revenue Growth Rate in Malignant Melanoma Drugs Business (2014-2019)
Table Hoffmann-La Roche Ltd Recent Development
Table Navidea Biopharmaceuticals Company Details
Table Navidea Biopharmaceuticals Revenue in Malignant Melanoma Drugs Business (2014-2019)(Million US$)
Figure Navidea Biopharmaceuticals Revenue Growth Rate in Malignant Melanoma Drugs Business (2014-2019)
Table Navidea Biopharmaceuticals Recent Development
Table Novartis Company Details
Table Novartis Revenue in Malignant Melanoma Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Malignant Melanoma Drugs Business (2014-2019)
Table Novartis Recent Development
Table Ono Pharmaceutical Company Details
Table Amgen Company Details
Table Global Malignant Melanoma Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Malignant Melanoma Drugs Market Size Share by Regions (2019-2025)
Figure Global Malignant Melanoma Drugs Market Size Share by Regions in 2025
Figure United States Malignant Melanoma Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Malignant Melanoma Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Malignant Melanoma Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Malignant Melanoma Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Malignant Melanoma Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Malignant Melanoma Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Malignant Melanoma Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Malignant Melanoma Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Malignant Melanoma Drugs Market Size by Product (2019-2025)
Figure Global Malignant Melanoma Drugs Market Size by Product in 2025
Table Global Malignant Melanoma Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Malignant Melanoma Drugs Market Size by Application (2019-2025)
Figure Global Malignant Melanoma Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の悪性神経膠腫薬市場：市場規模・現状・予測

Global Malignant Glioma Drugs Market Size, Status and Forecast 2019-2025
QYR9N7501 2019年6月14日 98Pages
当資料は、悪性神経膠腫薬のグローバル市場について調査・分析したレポートで、種類別（アルキル化剤、VEGF / VEGFR阻害剤、抗血管新生薬）、用途別（病院、がん研究機関、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業...

世界の悪性中皮腫薬市場：市場規模・現状・予測

Global Malignant Mesothelioma Drugs Market Size, Status and Forecast 2019-2025
QYR9N7505 2019年6月14日 103Pages
当資料は、悪性中皮腫薬のグローバル市場について調査・分析したレポートで、種類別（ペメトレキセド、シスプラチン、カルボプラチン、ゲムシタビン、ビノレルビン、その他）、用途別（病院薬局、小売薬局、腫瘍センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...

世界の悪性神経膠腫市場：市場規模・現状・予測

Global Malignant Glioma Market Size, Status and Forecast 2019-2025
QYR9N7500 2019年6月14日 92Pages
当資料は、悪性神経膠腫のグローバル市場について調査・分析したレポートで、種類別（化学療法、薬物）、用途別（病院、がん研究機関、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の悪性リンパ腫市場：市場規模・現状・予測

Global Malignant Lymphoma Market Size, Status and Forecast 2019-2025
QYR9N7502 2019年6月14日 99Pages
当資料は、悪性リンパ腫のグローバル市場について調査・分析したレポートで、種類別（ホジキンリンパ腫、非ホジキンリンパ腫）、用途別（製薬会社、病院、学術研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の黒色腫市場：市場規模・現状・予測

Global Melanoma Market Size, Status and Forecast 2019-2025
QYR9N7532 2019年6月14日 97Pages
当資料は、黒色腫のグローバル市場について調査・分析したレポートで、種類別（表在性黒色腫、結節性黒色腫、悪性ほくろメラノーマ、先天性）、用途別（病院、製薬会社、研究センター、診療所、実験室）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界の黒色腫の検出市場：市場規模・現状・予測

Global Melanoma Detection Market Size, Status and Forecast 2019-2025
QYR9N7534 2019年6月14日 98Pages
当資料は、黒色腫の検出のグローバル市場について調査・分析したレポートで、種類別（生検、イメージング、その他）、用途別（病院、スキンケアクリニック、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...

世界の黒色腫がん市場：市場規模・現状・予測

Global Melanoma Cancer Market Size, Status and Forecast 2019-2025
QYR9N7533 2019年6月14日 96Pages
当資料は、黒色腫がんのグローバル市場について調査・分析したレポートで、種類別（非侵襲性黒色腫、浸潤性黒色腫）、用途別（病院、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

...

世界のメラノーマ治療薬市場：市場規模・現状・予測

Global Melanoma Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7535 2019年6月14日 90Pages
当資料は、メラノーマ治療薬のグローバル市場について調査・分析したレポートで、種類別（オプディボ、イェルボイ、メカニスト+タフィラー、キートルダ、コテリック、その他）、用途別（アストラゼネカ、アムジェン株式会社、F.ホフマン - ラロッシュ社、ブリストル・マイヤーズスクイブ社、ノバルティスAG、その他...

世界の悪性中皮腫市場：市場規模・現状・予測

Global Malignant Mesothelioma Market Size, Status and Forecast 2019-2025
QYR9N7504 2019年6月14日 109Pages
当資料は、悪性中皮腫のグローバル市場について調査・分析したレポートで、種類別（経口、非経口）、用途別（病院薬局、小売薬局、腫瘍センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の悪性中皮腫治療市場：市場規模・現状・予測

Global Malignant Mesothelioma Therapeutic Market Size, Status and Forecast 2019-2025
QYR9N7506 2019年6月14日 105Pages
当資料は、悪性中皮腫治療のグローバル市場について調査・分析したレポートで、種類別（経口、非経口）、用途別（病院薬局、小売薬局、腫瘍センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の悪性神経膠腫薬市場：市場規模・現状・予測 Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers.In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and pr…
世界の悪性中皮腫薬市場：市場規模・現状・予測 Mesothelioma is a type of cancer that develops from the thin layer of tissue that covers many of the internal organs (known as the mesothelium).Our research indicates that the hospital pharmacies distribution channel segment is expected to witness a significant rise in revenue share over the forecas…
世界のメラノーマ治療薬市場：市場規模・現状・予測 In 2018, the global Melanoma Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Melanoma Therapeutics status, future forecast, growth opportunity, key market and key players. The stud…
世界の悪性神経膠腫市場：市場規模・現状・予測 Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers.In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and pr…
世界の悪性リンパ腫市場：市場規模・現状・予測 Cancers that start anywhere in the body’s lymphatic system are called lymphomas. If they have the ability to spread, they are called malignant. The lymphatic system runs throughout our bodies and is composed of lymphoid tissue, vessels, and fluid. Lymphoid tissue contains lymph nodes, which are part…